University of Vermont Study Opens New Door for Mesothelioma Treatment

Researchers at UVM Cancer Center have begun their first in-human clinical trial of the potentially groundbreaking new drug RSO-021.

Related Keywords

Boston ,Massachusetts ,United States ,United Kingdom ,Vermont ,Brian Cunniff ,Jarrett Duncan ,Mesothelioma Center At Asbestos ,Brian Cunniff University Of Vermont ,Wake Forest University School Of Medicine ,University Of Vermont Cancer Center ,Cunniff Lab ,Laboratory Medicine ,Department Of Pathology ,University Of Vermont ,University Of Vermont Plays Key Role ,Vermont Cancer Center ,Mesothelioma Center ,Trial Is First ,Vermont Plays Key ,Wake Forest University School ,Mesothelioma Treatment ,